Novavax announced Monday that it has formally submitted a request for the US Food and Drug Administration to authorize its coronavirus vaccine for emergency use in the United States The request is based on data that includes the results of two large clinical trials that demonstrated an overall...
31 business novavax vaccine fda
booster novavaxs coronavirus vaccine
country: united states
covid alternative novavax vaccine
fda emergency use authorization
novavaxsadjuvant
protein based vaccine platform
small laboratory built pieces
stanley erck novavaxs president
two large clinical trials
